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INTRODUCTION
Split-thickness skin grafts (STSGs) are an integral 
part of the reconstructive armamentarium and serve a 
fundamental role in the treatment of burn, traumatic, 
and chronic wounds. Consisting of the epidermis with 
varying thicknesses of underlying dermis, a STSG of-
fers several benefits beyond simple wound coverage.1–7 
 According to the Healthcare Cost and Utilization Proj-
ect, over 160,000 skin grafts are performed annually in 
nearly 1 out of 3 burn hospitalizations.8 Their use is pop-
ular, as they are relatively easy and expedient, provided 
adequate donor tissue and a healthy recipient bed are 
available.
Once an STSG is harvested, an iatrogenic wound re-
mains at the donor site that heals by reepithelialization 
from underlying dermal appendages over 7–10 days.9 
Not infrequently, patients report high levels of pain at 
the donor site(s) resulting in lengthier hospitalizations, 
increased analgesic consumption, and impairment in 
functional activity that may delay overall recovery and 
early mobilization.10–15 Consequently, palliation of donor-
site pain via different dressing preparations is a subject of 
clinical interest and ongoing debate.
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The purpose of this systematic review was to analyze the most recent outcomes 
regarding moist and nonmoist dressings for STSG donor sites.
Methods: A comprehensive systematic review was conducted across PubMed/
MEDLINE, EMBASE, and Cochrane Library databases to search for comparative 
studies evaluating different STSG donor-site dressings in adult subjects published 
between 2008 and 2017. The quality of randomized controlled trials was assessed 
using the Jadad scale. Data were collected on donor-site pain, rate of epithelializa-
tion, infection rate, cosmetic appearance, and cost. Meta-analysis was performed 
for reported pain scores.
Results: A total of 41 articles were included comparing 44 dressings. Selected stud-
ies included analysis of donor-site pain (36 of 41 articles), rate of epithelialization 
(38 of 41), infection rate (25 of 41), cosmetic appearance (20 of 41), and cost (10 
of 41). Meta-analysis revealed moist dressings result in lower pain (pooled effect 
size = 1.44). A majority of articles (73%) reported better reepithelialization rates 
with moist dressings.
Conclusion: The literature on STSG donor-site dressings has not yet identified an 
ideal dressing. Although moist dressings provide superior outcomes with regard to 
pain control and wound healing, there continues to be a lack of standardization. 
The increasing commercial availability and marketing of novel dressings necessi-
tates the development of standardized research protocols to design better compari-
son studies and assess true efficacy. (Plast Reconstr Surg Glob Open 2018;6:e1928; doi: 
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In recent years, there has been an increasing number of 
commercially available dressings for STSG donor sites.16–23 
Dressings are categorized as moist (eg, Aquacel, Kaltostat, 
Mepitel, Tegaderm) and nonmoist (eg, Xeroform, paraf-
fin-impregnated gauze), depending on their ability to re-
tain moisture upon application. Moist dressings provide 
an environment that prevents desiccation and are nonad-
herent to the wound bed, whereas nonmoist dry dressings 
possess no barrier to contain the extracellular fluid within 
the wound.2,24 In clinical practice, the choice to use moist 
versus nonmoist dressings largely remains based on sur-
geon preference without clear evidence-based consensus 
from the literature.
Three systematic reviews comparing different do-
nor-site dressings have been published over the last 20 
years.2,25,26 In the interim, new dressings have been intro-
duced and higher quality comparison studies have been 
published that warrant revisiting this topic to include new-
er evidence.
METHODS
Literature Review
A systematic review was performed using PRISMA 
guidelines.27 Comprehensive literature searches were 
conducted in the PubMed/MEDLINE, EMBASE, and 
Cochrane Library online databases in June 2017 by 2 in-
dependent reviewers (A.T.S. and B.B.P.). The following 
key words were used independently and in combination 
to identify full-text articles published in English between 
2008 and 2017: “skin graft,” “donor,” “dressing.” This time 
range was chosen to allow focus on data published since 
the previous review article. Articles were considered if they 
were comparative studies evaluating different STSG do-
nor-site dressings in adult human subjects. Abstracts, case 
reports/series, studies with fewer than 10 subjects, review 
articles, surveys, letters to the editor, and meeting pro-
ceedings were excluded. Articles comparing STSG donor-
site dressings in pediatric patients, and articles comparing 
secondary dressings, topical creams, sprays, or ancillary 
interventions (eg, ultrasound, extracorporeal shock wave 
therapy, active micro-current application, intradermal in-
jections) were also excluded. Following database query 
and duplicate study removal, the titles and abstracts of 
the remaining preliminary studies were reviewed. Cross-
referencing of included studies was then performed. Any 
disagreement was resolved through involvement of the se-
nior author (I.S.).
Descriptive outcomes collected for each study includ-
ed the following: year of publication, study type, number 
of subjects, follow-up duration, subject age, sex, diagnoses, 
donor dressings, location of donor site(s), and primary 
outcome measures (pain, reepithelialization, infection 
rate, cosmetic outcome, and cost).
Quality Assessment
Methodological quality of randomized control trials 
(RCTs) was assessed using the Jadad Scale/Oxford Qual-
ity Scoring System. This system provides a method of iden-
tifying potential levels of bias by scoring each study with 
regard to randomization, blinding, intrastudy withdrawals 
and drop-outs.28 One independent reviewer (D.V.) scored 
each eligible study included in this review.
Data Synthesis and Meta-analysis
A meta-analysis was performed for pain among articles 
that reported Visual Analog Scale (VAS) scores. Mean 
VAS, SD, and the number of patients in each group (moist 
and nonmoist) were used to calculate the Hedges’ g as 
an indicator of effect size for each study. We combined 
continuous assessments of pain using Hedges’ g, which is 
a “bias adjusted” measure of the Standardized Mean Dif-
ference and expresses the intervention effect in standard 
units rather than the original units of measurement.29 
Meta-analysis was not performed for the remainder of out-
come measures due to heterogeneity in study designs and 
lack of standardized outcome measurements.
If data were presented in 95% confidence intervals, 
the SD was calculated with the following formula: SD = 
95% CI/1.96 × √n. When the median and range were re-
ported for continuous outcomes, the mean and SD were 
estimated by assuming that the mean was equivalent to the 
median and that the SD is a quarter of the range. If no 
SD was given, the SD was estimated as half of the mean 
value. Hedges’ g also can be calculated with the propor-
tion of “pain free” patients in each study arm or with the 
mean difference correspondent P values between 2 study 
groups.30
To address heterogeneity among individual studies, Co-
chran’s Q statistic and I2 were calculated. A P value of 0.10 
or less was set to determine statistical significance.31 In the 
case of significant heterogeneity, a random effect analysis 
was employed. Otherwise, a fixed effect analysis was em-
ployed. To evaluate for the presence of publication bias, 
the Begg-Mazumdar test (with a P < 0.05 indicating statisti-
cally significant) was used.32
A time-point subanalysis was performed. Postopera-
tive pain measurement time points were categorized into 
3 groups: less than 4 days, 4–7 days, and 8+ days postop-
erative. Whenever multiple measurements in a time span 
were reported, we used the measurements from the lon-
gest follow-up time.
RESULTS
Literature Search and Study Characteristics
The literature search identified 510 articles (Fig. 1). 
After review and implementing exclusion criteria, 41 ar-
ticles were included (Table 1). The majority of included 
articles were prospective RCTs (35 of 41 studies, Fig. 2). 
The remaining articles included prospective case series (1 
article), comparison cohort clinical trial (1 article), pro-
spective controlled matched pair studies (2 articles), or 
unspecified (3 articles). Patient diagnoses were described 
in 23 of 41 articles and included patients with burn inju-
ries, chronic ulcers, traumatic wounds, wounds resulting 
from tumor resection (skin, bone, or unspecified), and 
extremity fasciotomies. A total of 44 different dressing 
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types were evaluated and compared. Moist versus non-
moist (22 articles), moist versus other moist (22 articles), 
and nonmoist versus other nonmoist dressings (1 article) 
were compared. Four articles compared multiple different 
dressing categories (eg, both moist versus nonmoist and 
moist versus moist).
Patient demographics, including age and sex, were re-
ported in 33 of 41 studies. Donor-site locations were also 
reported in 33 of 41 articles, with the lateral thigh donor 
site utilized most frequently. Other donor sites included 
back (2 articles), chest (1 article), arm (1 article), lateral 
Fig. 1. Flow chart for included studies.
Table 1.  Number of Included Articles by Specific Outcome 
Measures
Outcome
No.  
Articles
No. comparing  
Moist Versus  
Nonmoist Dressings
Total n = 41 n = 22
Pain, n (%) 36 (87.8) 22 (100)
Wound healing, n (%) 38 (92.7) 22 (100)
Infection, n (%) 25 (61) 15 (68.2)
Cosmetic outcome, n (%) 20 (48.8) 10 (45.5)
Cost, n (%) 10 (24.4) 5 (22.7)
Fig. 2. Study types that met inclusion criteria.
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trunk (1 article), buttock (1 article), and lower leg (1 ar-
ticle). Mean follow-up duration ranged from 9 days to 1 
year and was either predetermined or set after study com-
mencement (eg, time to complete reepithelialization).
Mean Jadad score for all included studies was 
1.54 ± 1.14. The funnel plot (Fig. 3) was not asymmetrical 
indicating the absence of publication bias. Similarly, Ma-
zumdar test assessing publication bias was not significant 
(P = 0.085).
Pain
Pain was evaluated in 36 of 41 articles by various as-
sessment methods (Table 2). Comparison of pain between 
moist and nonmoist dressings was performed in 22 arti-
cles, with 19 articles (86%) reporting lower pain scores 
with moist dressings. The remaining 3 articles reported 
no difference in pain between moist and nonmoist dress-
ings. Sufficient data for quantitative analysis comparing 
pain intensity between moist and nonmoist dressings 
was reported in 21 articles. Eight of these articles did not 
report time of pain assessment and were therefore only 
entered in the overall analysis. The remaining 13 articles 
were included in a subgroup analysis based on time of 
pain assessment. The meta-analysis showed patients with 
moist dressings had significantly lower pain at all time 
points compared with nonmoist dressings (Fig. 4). Moist 
dressings appeared to be most effective in short-term as-
sessments (Standardized Mean Difference = 1.32; 95% CI, 
0.49–2.14); however, there was no significant difference in 
size of the effect among 3 assessed time points (P = 0.69; 
Table 3).
Wound Healing
Reepithelialization rate and/or quality of healing 
between dressing types was reported in 38 of 41 articles. 
Comparison between moist and nonmoist dressings was 
performed in 22 articles, with 16 articles (73%) reporting 
a better reepithelialization rate and/or quality with moist 
dressings. Five articles reported no difference in reepithe-
lialization rate and/or quality, and 1 article reported bet-
ter reepithelialization with a nonmoist dressing.
Donor site wound healing was defined in most articles 
as time elapsed between STSG harvest and complete do-
nor-site reepithelialization (30 articles). In the remainder 
of articles, healing was defined by the amount of reepi-
thelialization at donor sites at a given time point (7 ar-
ticles) or average per day reepithelialization (1 article). 
Complete reepithelialization was determined by sponta-
neous detachment of the applied dressing or by clinical 
examination.
Infection
Infection rate was reported in 25 of 41 articles and 
was defined by the presence of clinical signs or symptoms 
(eg, wound site erythema, purulence, and/or exudate). 
Overall, infection rates were low. Seven articles reported 
no infections, and the highest reported infection rate was 
24%. The comparison of infection rates between moist 
and nonmoist dressings was reported in 15 articles, with 
3 articles reporting higher infection rates with nonmoist 
dressings, 1 article reporting higher rates using a moist 
dressing, and the remainder (73%) reporting either no 
infections or no difference. Differences were not reported 
to be statistically significant.
Fig. 3. Funnel plot of standard error indicating absence of significant publication bias.
Table 2. Pain Outcome Assessment Methods Used in the 
Included Articles
Method of Assessment No. Articles*
VAS 25
Linear Analogue Self-Assessment (LASA) 1
Brief Pain Inventory (BPI) 1
Index of Pain Management (IPM) 1
Patient questionnaire or cooperation scale 9
Numeric Pain Rating (NPR) 1
*Total number of articles equals greater than 36 due to 1 article including 3 
types of measurement tools.
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Cosmetic Outcome
Cosmetic outcome was reported in 20 of 41 articles 
with the majority of articles reporting no difference in 
cosmetic outcome between different dressing types. Com-
parisons between moist and nonmoist dressings were re-
ported in 10 articles. Three articles (30%) reported better 
cosmetic outcomes using moist dressings, 2 articles (20%) 
reported better outcomes using nonmoist dressings, and 
5 articles (50%) reported no difference. Assessment was 
performed using the modified Vancouver Scar Scale 
(VSS), Patient and Observer Scar Assessment Scale (PO-
SAS), wound evaluation by clinicians and/or patients, or 
photo review by clinicians (Table 4). Two articles did not 
specify cosmetic assessment methods.
Cost
Descriptive comparisons of cost were performed in 10 
of 41 articles with 5 articles (50%) comparing moist and 
nonmoist dressings. Two articles (40%) concluded moist 
dressings to be more cost effective. One article (20%) 
concluded nonmoist dressing to be more cost effective, 
and 2 articles (40%) found no difference. Cost compari-
son was performed using either cost per square centime-
ter of dressing, nursing labor and/or time spent by staff, 
or amount of waste produced.
DISCUSSION
Despite continued publication of RCTs and the devel-
opment of novel dressings, the optimal STSG donor-site 
dressing choice remains unclear. Our article builds upon 
the existing literature by providing an updated review and 
a new meta-analysis on pain scores using validated guide-
lines. We are able to associate moist dressings with better 
pain scores and wound healing, whereas infection rate, 
cosmetic outcome, and costs do not significantly differ be-
tween moist and nonmoist dressings. In addition, our re-
view provides novel recommendations for future studies.
Traditionally, dressings for STSG donor sites are cat-
egorized as moist and nonmoist. Further categorization 
includes occlusive (eg, hydrogels, hydrocolloids), semioc-
Fig. 4. Meta-analysis of pain scores comparing moist vs. nonmoist dressings.
Table 3. Subanalysis of Postoperative Pain Comparing Moist and Nonmoist Dressings at Different Time Points
Time Point (Postoperative Day) No. Articles No. Subjects Hedges’ g (CI) P I2 (%)
1–4 d 7 290 1.32 (0.49–2.14) 0.002 89.9
4–7 d 12 531 0.92 (0.45–1.40) < 0.001 85.6
8 d or more 6 284 1.16 (0.37–1.96) 0.004 83.2
Overall* 13 561 1.28 (0.84–1.73) 0.687<0.001 85.9
*Cross comparison of the effect size in different time points is not significant (p=0.687)
Table 4. Cosmetic Outcome Assessment Methods Used in 
the Included Articles
Method of Assessment No. Articles*
VSS; includes modified versions 9
POSAS 2
Photo review 5
Scar evaluation by patient 4
Scar evaluation by clinician 2
Unspecified 2
*Total number of articles equals greater than 20 due to multiple articles includ-
ing more than 1 measurement tool.
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clusive (eg, polyethylene film), or “exposure” dressings—
where occlusive dressings completely seal off wounds and 
surrounding tissue from air, fluids, and possible contami-
nants.33 Both occlusive and semiocclusive dressings are in-
cluded in the moist subgroup in this review.
Of the 22 articles comparing pain between moist and 
nonmoist dressings, pooled data show significantly lower 
pain scores with moist dressings. Additionally, pain was 
significantly lower with moist dressings at all postopera-
tive time points in the subanalysis performed. Evaluation 
of reepithelialization involved various methods such as 
time elapsed until spontaneous detachment of the dress-
ing or serial subjective evaluations by an experienced cli-
nician. A number of studies evaluated reepithelialization 
rates (expressed as a percentage of total wound area) at a 
predetermined follow-up time point. The majority of ar-
ticles reported moist dressings associated with improved 
wound healing.
Infection rates, cosmetic outcomes, and cost were re-
ported in fewer articles. Infection rates were very low over-
all, and differences between dressing types were minor 
with no strong evidence to support the use of a specific 
dressing type. Cosmetic outcomes, reported in almost half 
of the included studies, found no clear evidence support-
ing the use of moist versus nonmoist dressings. Eleven of 
the 20 articles reporting cosmetic outcomes used validat-
ed scar outcome scales such as VSS or POSAS. Important-
ly, the VSS does not take patient perception into account, 
whereas POSAS incorporates subjective patient assess-
ments.34 Finally, studies either reported cost in terms of 
direct monetary dressing value, or by incorporating vari-
ables such as patient length of stay and nursing labor costs 
for a more comprehensive cost assessment. When factor-
ing all variables, there remains weak evidence to support 
the use of a specific dressing.
Three previous systematic reviews on STSG donor-
site dressings have been published (Table 5).2,25,26 Rakel 
et al.25 reviewed 33 studies published between 1968 and 
1996 and reported outcome measures including pain, in-
fection, healing quality/rate, and cost. Major drawbacks 
of this review were that no definitive search criteria were 
described, and no quality assessment tools were utilized 
for the included studies. In 2003, Wiechula26 compared 
moist with nonmoist STSG donor-site dressings through 
evaluation of 58 studies and found that moist dressings 
were associated with faster healing, lower infection rates, 
and decreased pain scores. However, no direct time limits 
were reported in their literature search. To describe study 
quality, a checklist was developed by the authors based on 
the work of the Cochrane Collaboration and Centre for 
Reviews and Dissemination. These 2 reviews concluded 
moist dressings have superior outcomes with regard to 
pain, infection, and healing.
Most recently, Voineskos et al.2 published a systematic 
review whose methodology adhered to established guide-
lines.35 They evaluated 72 studies published between 1971 
and 2008 meeting specific inclusion and exclusion crite-
ria. All methods for selecting studies were outlined, and 
the authors concluded moist dressings were associated 
with overall lower pain. In contrast to Wiechula,26 the au-
thors did not find evidence to support moist dressings for 
reducing infection rates. Due to the heterogeneity of the 
studies included in their review, a meta-analysis was not 
performed, and study quality using the Jadad scale found 
low overall quality among the included studies (average 
score, 1.7 ± 0.7).
In all previous reviews, study quality was inherently 
poor due to methodological heterogeneity, poorly de-
fined primary outcomes, and little use of existing validat-
ed measurement scales for pain and patient quality of life. 
Our review revealed similar methodological issues with 
large variations in outcome assessment tools. Specifically, 
pain outcomes were measured using various scales rang-
ing from VAS to patient questionnaires. In addition, the 
articles in our review seldom used quality of life metrics 
or considered treatment intervention from the patient’s 
point of view.
The inherent weakness of our review is the heteroge-
neity and overall low quality of the included studies. The 
mean Jadad score for included studies was 1.54 ± 1.14 with 
scores ranging from 0 to 3. It was impossible for articles 
to achieve a maximum Jadad score of 5, because double-
blinding these studies is not possible. Lack of consistency 
in outcome measures and poor study designs continue to 
Table 5. Previously Published STSG Donor-site Dressing Review Articles
First  
Author Year Inclusion Criteria
No.  
Articles Notable Key Findings
Voineskos 2009 Articles published between 1971 and 2008 that 
included
72 Pain: Moist dressings associated with less pain compared 
with nonmoist.
  1) patients requiring STSG donor dressing
2) review articles or comparative studies of STSG 
donor dressings
3) full report available
 Infection/healing quality: Limited evidence to support 
superiority of moist or nonmoist dressing.
   Healing rate: Moist dressings associated with faster  
healing rate.    
Wiechula 2003 Time limits not reported.
Intraindividual and prospective RCTs of patients of 
any age requiring STSG donor dressings.
58 Moist dressings are favored in terms of healing rate, pain, 
and infection.
 
   
Rakel 1998 Articles published between 1966 and 1996 that  
compared dressings applied to STSG donor site.
33 Pain: Transparent film and hydrocolloid dressings are 
associated with lower pain scores.
    Healing rate: Transparent film and hydrocolloid are 
superior.
    Infection: Many STSG donor-site dressings are associated 
with low infection rates.
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plague the literature, although certain improvements are 
evident. Increased utilization of validated pain and scar 
scales are seen.19,22,23,36–53 Vast differences among the includ-
ed dressings weaken this review. Well-established dressings 
are being compared with novel dressings being studied for 
the first time without standardized means for comparison.
Novel Dressings
Systematically reviewing the literature and the inclusion 
of the most recently published work strengthen this review. 
Innovative dressing materials developed recently range 
from bioelectric dressings, bilayered silk gelatin, dress-
ings with novel ointments including Triterpine, and new 
dermal substitutes. In a recent study surveying burn-care 
specialists, the “ideal” burn wound dressing was described 
as having properties of nonadhesion, absorbency, and anti-
microbial activity.54 Goertz et al.18 describe a solidifying gel 
that dissolves according to temperature, providing a more 
user-friendly interface for patients with superficial wounds. 
Specifically, their novel gel is liquid at room temperature 
and hardens to a gel consistency at or above normal body 
temperatures resulting in lower pain and superior results 
in terms of staining, leakage, and odor when compared 
with silver sulfadiazine gauze. Another promising dressing 
recently described in nonhuman studies includes a gell-
ing dendritic hydrogel-based dressing possessing thioes-
ter linkages that is able to dissolve on demand.55–58 The 
ability to apply a gel that solidifies within several minutes 
simplifies the dressing application process significantly. In 
vivo model studies have shown these gels achieve effective 
hemostasis and prevent infection while providing a moist 
environment for wound healing. Furthermore, a powerful 
feature is the ability for clinicians to dissolve the dressing 
on-demand for atraumatic dressing removals. Antibacterial 
chitosan-based gelling fiber dressings (Opticell Ag+) have 
also been introduced recently, providing a moist, conform-
able, highly absorbable dressing with antimicrobial activity 
to limit dressing changes and alleviate pain.59 Finally, stem 
cell therapy and lasers round out innovations that are serv-
ing as the frontier for burn and wound care.60,61
Future Studies
Despite a plethora of studies, the literature on STSG 
donor-site dressings continues to be plagued by inconsis-
tencies in research methodology. This literature review 
identified significant methodological issues including 
lack of standard study design and outcome criteria. Level 
I evidence is easily attainable. Future RCTs should use 
validated assessment instruments to report all outcome 
measures, ideally incorporating patient-reported outcome 
measures. Trials should be targeted toward patients with 
similar indications and common disease patterns. Postop-
erative dressing protocols and length of follow-up should 
be standardized. Finally, observational cohorts may be de-
signed to identify predictors of treatment outcomes.
CONCLUSIONS
Moist dressings provide superior outcomes with regard 
to pain and wound healing. However, there continues to 
be a lack of standardization for performing comparison 
studies between different dressing types. The increas-
ing number of novel dressings necessitates the develop-
ment of standardized research protocols to design better 
comparison studies. Given the clinical need for STSG 
donor-site dressings, significant opportunities exist for the 
continued development of new dressings, along with clini-
cal trials using defined quantitative metrics of success, to 
improve patient care.
Arman T. Serebrakian, MD, MS
Division of Plastic Surgery
Brigham and Women’s Hospital
75 Francis Street
Boston, MA 02115
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